Techno Drugs Ltd TECHNODRUG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 132.00M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 21.72
- Price/Sales
- 1.42
- Dividend Yield (Trailing)
- 3.00%
- Dividend Yield (Forward)
- 3.00%
- Dividend Payment Schedule
- Feb
- Total Yield
- 3.00%
Company Profile
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 1,438
- Website
- https://www.technodrugsltd.com
Valuation
|
Metric
|
TECHNODRUG
|
|---|---|
Price/Earnings (Normalized) | 21.72 |
Price/Book Value | 1.06 |
Price/Sales | 1.42 |
Price/Cash Flow | 6.83 |
Price/Earnings
TECHNODRUG
Financial Strength
|
Metric
|
TECHNODRUG
|
|---|---|
Quick Ratio | 1.37 |
Current Ratio | 3.27 |
Interest Coverage | 1.62 |
Quick Ratio
TECHNODRUG
Profitability
|
Metric
|
TECHNODRUG
|
|---|---|
Return on Assets (Normalized) | 2.72% |
Return on Equity (Normalized) | 4.97% |
Return on Invested Capital (Normalized) | 7.76% |
Return on Assets
TECHNODRUG
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|$PCx&$K! | LOCK|rQK$$ | $69B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|T>NL>Wgs | LOCK|C!@% | $47B | |||
| Haleon PLC ADR
HLN
| LOCK|b@y!fq | LOCK|x< | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|@Zk>Dy> | LOCK|%W% | $33B | |||
| Viatris Inc
VTRS
| LOCK|HsvCk% | LOCK|n$P | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|Zl | LOCK|T#l | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|^w#LjN | LOCK|bJR | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|$dT<CtC | LOCK|C<% | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|JL^##!! | LOCK|sg<G& | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|y>Xj$s | LOCK|<>y | $2B |
United States